Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
|
Outline of Final Research Achievements |
Impaired glucose tolerance is a pre-diabetic state of type 2 diabetes mellitus (T2DM) that is associated with either insulin resistance, low insulin production or both. Early detection and therapeutic treatment of impaired glucose tolerance is now attracting attention as a prophylactic treatment strategy. In this study, we developed a T2DM model zebrafish and identified novel therapeutic targets gene (such as hmox1) by RNA-seq analysis. Knockdown study of these genes ameliorated the T2DM phenotypes including glucose intolerance.
|